What's new

Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Status: Opinion

Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Status: Opinion

Jun 20, 2025 - 12:25
 0
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Status: Opinion
Human medicines European public assessment report (EPAR): Zemcelpro, allogeneic umbilical cord-derived CD34- cells, non-expanded,dorocubicel, Status: Opinion
Read More

Tags:

Previous Article

Referral: Finasteride- and dutasteride-containing medicinal products, finasterid...

Next Article

Human medicines European public assessment report (EPAR): Vivlipeg, pegfilgrasti...

Related Posts

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 17, 2025  0

EU Medicines Assessment - Opportunities for expert involvement, Online, European Medicines Agency, Amsterdam, the Netherlands, from 9 July 2025, 15:00 (CEST) to 9 July 2025, 16:15 (CEST)

EU Medicines Assessment - Opportunities for expert invo...

Jun 5, 2025  0

Human medicines European public assessment report (EPAR): Abrysvo, Respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0